[1] Vidyasagar, D., Uhal, B., Bhat, R., Navale, S. and Zagariya, A. (2004) The TNF, IL-1, IL-6, IL-8, IL-10 and INGg cytokine expression in meconium-instilled newborn lungs. Indian Journal of Pediatrics, 71, 195-102.
[2] Wisnievsky, M., Zagariya, A., Pavuluri, N., Shrinivasan, H., Navale, S. and Vidyasagar, D. (2005) Meconium induces injury in anoxic isolated perfused rat lungs. Pediatric Pulmonology, 39, 368-373.
[3] Vidyasagar, D., Lukkarinen, H., Kaapa, P. and Zagariya, A. (2005) Inflammatory responce and apoptosis in newborn lungs after meconium aspiration. Biotechnology Progress, 21, 192-197. doi:10.1021/bp0497886
[4] Zagariya, A., Bhat, R., Uhal, B., Navale, S. and Vidyasagar, D. (2005) Apoptosis of airway epithelial cells in response to meconium. Life Sciences, 76, 1849-1858. doi:10.1016/j.lfs.2004.10.033
[5] Zagariya, A., Bhat, R., Uhal, B., Navale, S., Freidine, M. and Vidyasagar, D. (2000) Cell death and lung cell histology in meconium aspirated newborn rabbit lung. European Journal of Pediatrics, 159, 819-826. doi:10.1007/s004310000581
[6] Zagariya, A., Bhat, R., Navale, S. and Vidyasagar, D. (2006) Inhibition of meconium-induced cytokine expression by Captopril. Pediatrics, 117, 1722-1727. doi:10.1542/peds.2005-0274
[7] Lukkarinen, H., Laine, J., Aho, H., Zagariya, A., Vidyasagar, D. and Kaapa, P. (2004) Angiotensin II receptor blockade inhibits pneumocyte apoptosis in experimental meconium aspiration. Pediatric Research, 55, 326-333. doi:10.1203/01.PDR.0000100901.88697.66
[8] Uhal, B.D., Wang, R., Laukka, J., Zhyang, J., Soledad-Conrad, V. and Filippatos, G. (2003) Inhibition of amiodarone-induced lung fibrosis but not alveolitis by angiotensin system antagonists. Pharmacology & Toxicology, 92, 81-87. doi:10.1034/j.1600-0773.2003.920204.x
[9] Doucet, C., Brouty-Boye, D., Pottin-Clemenceau, C., Canonica, G.W., Jasmin, C. and Azzarone, B. (1998) Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma. Journal of Clinical Investigation, 101, 2129-2139. doi:10.1172/JCI741
[10] Murata, T., Orobi, N.I., Debinski, W. and Puri, R.K. (1997) Structure of IL-13 receptor: Analysis of subunit composition in cancer and immune cells. Biochemical and Biophysical Research Communications, 238, 90-94. doi:10.1006/bbrc.1997.7248
[11] Toru, H., Pawankar, R., Ra, C., Yata, J. and Nakahata, T. (1998) Human mast cells produce IL-13 by high-affinity IgE receptor cross-linking: enhanced IL-13 production by IL-4 primed human mast cells. Journal of Allergy and Clinical Immunology, 102, 491-502. doi:10.1016/S0091-6749(98)70140-X
[12] Murata, T., Hussain, S.R., Mohri, H. and Puri, R.K. (1998) Two different receptor chains are expressed in normal human skin fibroblasts, and IL-4 and IL-13 mediate signal transduction through a common pathway. International Immunology, 10, 1103-1110. doi:10.1093/intimm/10.8.1103
[13] Brombacher, F. (2000) The role of interleukin 13 in infectious disease and allergy. BioEssays, 22, 646-656. doi:10.1002/1521-1878(200007)22:7<646::AID-BIES7>3.0.CO;2-9
[14] Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T.Y., Karp, C.L. and Donaldson, D.D. (1998) Interleukin IL-13: Central mediator of allergic astma. Science, 282, 2258. doi:10.1126/science.282.5397.2258
[15] Kawakami, M., Kawakami, K. and Puri, R.K. (2002) Apoptotic pathways of cell death induced by an interleukin-13 receptor-targeted recombinant cytotoxin in head and neck cancer cells. Cancer Immunology, Immunotherapy, 50, 691-700. doi:10.1007/s00262-001-0242-6
[16] Belperio, J.A., Dy, M., Burdick, M.D., Xue, Y.Y., Li, K.J.A. and Elias, M.P. (2002) Keane Interaction of IL-13 and C10 in the pathogenesis of bleomycin-induced pulmonary fibrosis. American Journal of Respiratory Cell and Molecular Biology, 27, 419.
[17] Oriente, A., Fedarko, N.S., Pacocha, S.E., Hugan, S.K., Lichtenstein, L.M. and Essayan, D.M. (2000) Interleukin 13 modulates collagen homeostasis in human skin and keloid fibroblasts. Journal of Pharmacology and Experimental Therapeutics, 292, 988-994.
[18] Chiaramonte, M.G., Donaldson, D.D., Cheever, A.W. and Wynn, T.A. (1999) An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. Journal of Clinical Investigation, 104, 777. doi:10.1172/JCI7325
[19] Chiaramonte, M.G., Donaldson, D.D., Cheever, A.W. and Wynn, T.A. (1999) An IL-13 inhibitor blocks the developmnt of hepatic fibrosis during a T-helper type 2-dominated inflammatory responce. Journal of Clinical Investigation, 104, 777-785. doi:10.1172/JCI7325
[20] Jakubzik, C., Kunkel, S.L., Joshi, B., Puri, R. and Hogaboam, C. (2002) Interleukin-13 fusion cytotoxin arrests Schistosoma mansoni Egg-induced pulmonary granuloma formation in mice. The American Journal of Pathology, 161, 1283-1297. doi:10.1016/S0002-9440(10)64405-7
[21] Zuo, F., Kaminski, N., Eugui, E,, Allard, J., Yakhini, Z., Ben-Dor, A., Lollini, L., Morris D., Kim, Y. and De Lustro, B. (2002) Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans. Proceedings of the National Academy of Sciences, 99, 6292. doi:10.1073/pnas.092134099
[22] Evanoff, H., Burdick, M.D., Moore, S.A., Kunkel, S.L. and Strieter, R.M. (1992) A sensitive ELISA foe the detection of human monocyte chemoattractant protein-1 (MCP-1). Immunological Investigations, 21, 39-49. doi:10.3109/08820139209069361
[23] Graves, P.E., Kabesch M., Halonen, C.J., Holberg, M., Baldini, C., Fritzsch, S.K., Weiland, R.P., Erickson, E. and Martinez, F.D. (2000) A cluster of seven tightly linked polymorphism in the IL-13 gene is associated with total serum IgE levels in three populations of white children. The Journal of Allergy and Clinical Immunology, 105, 506-513. doi:10.1067/mai.2000.104940
[24] Uhal, B.D., Gidea, C., Bargout, R., Bifero, A., Ibarra-Sunga, O., Papp, M., Flynn, K. and Filippatos, G. (1998) Captopril inhibits apoptosis in human lung epithelial cells: A potential antifibrotic mechanism. American Journal of Physiology, 275, L1013-L1017.
[25] Zheng, T., Zhu, Z., Wang, Z., Homer, R.J., Ma, B., Riese, R.J., Chapman, H.A., Shapiro, S.D. and Elias, J.A. (2000) Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. Journal of Clinical Investigation, 106, 1081-1093. doi:10.1172/JCI10458
[26] Gordon, S. (2003) Alternative activation of macrophages. Nature Reviews Immunology, 3, 23. doi:10.1038/nri978
[27] Carre, P.C., Mortenson, R.L., King, T.E., Noble, P.W., Sable, C.L. and Riches, D.W. (1991) Increased expression of the interleukin-8 gene by alveolar macrophages in idiopatic pulmonary fibrosis. Journal of Clinical Investigation, 88, 1802. doi:10.1172/JCI115501
[28] Matrinet, Y., Rom, W.N., Grotendorst, G.R., Martin, R.G. and Crystal, R.G. (1987) Exagerated spontaneous release of plateled-derived growth factor by alveolar macrophages from patients with idiopatic pulmonary fibrosis. The New England Journal of Medicine, 317, 202. doi:10.1056/NEJM198707233170404
[29] Smith, R.E., Strieter, R.M., Zhang, K., Phan, S.H., Standiford, T.J., Lukacs, N.W. and Kunkel, S.L. (1995) A role for C-C chemokines in fibrotic lung disease. Journal of Leukocyte Biology, 57, 782.
[30] Lee, C.G., Homer, R.J., Zhu, Z., Lanone, S., Wang, X., Koteliansky, V., Shipley, J.M., Gotwals, P., Noble, P., Chen, Q., Senior, R.M. and Elias, J.A. (2001) Interleukin IL-13 induces tissue fibrosis by selectively stimulating and activating transforming factor beta(1). The Journal of Experimental Medicine, 194, 809-821. doi:10.1084/jem.194.6.809
[31] Oriente, A., Fedarko, N.S., Pacocha, S.E., Huang, S.K., Lichtenstein, L.M. and Essayan, D.M. (2000) Interleukin IL-13 modulated collagen homeostasis in human skin and keloid fibroblasts. Journal of Pharmacology and Experimental Therapeutics, 292, 988-994.
[32] Kunkel, S.L., Lukacs, N.W., Strieter, R.M. and Chensue, S.W. (1996) Th1 and Th2 responces regulate experimental lung granuloma development. Sarcoidosis, Vasculitis and Diffuse Lung Diseases, 160, 481-490.
[33] McKenzie, A.N., Culpepper, J.A., de Malefut, W., Briere, F., Pummonen, J., Aversa, G., Sato, A., Dana, W., Cocks, B.G. and Menon, S. (1993) Interleukin IL-13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proceedings of the National Academy of Sciences, 90, 3735. doi:10.1073/pnas.90.8.3735
[34] Burd, P.R., Thompson, W.C., Max, E.E. and Mills, F.C. (1995) Activated mast cells produce interleukin IL-13. The Journal of Experimental Medicine, 181, 1373. doi:10.1084/jem.181.4.1373
[35] Hancock, A., Armstrong, L., Gama, R., Millar, A. (1998) Production of interleukin IL-13 by alveolar macrophages from normal and fibrotic lungs. American Journal of Respiratory Cell and Molecular Biology, 18, 60.
[36] Hancock, A., Armstrong, L., Gama, R. and Millar, A. (1998) Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung. American Journal of Respiratory Cell and Molecular Biology, 18, 60.
[37] Fine, A., Janssen-Heininger, Y., Soultanakis, R.P., Swisher, S.G. and Uhal, B.D. (2000) Apoptosis in lung pathophysiology. American Journal of Physiology, 279, L423-L427.
[38] Soengas, M.S., Alarcon, R.M., Yoshida, H., Giaccia, A.J., Hakem, R., Mak, T.W. and Lowe, S.W. (1999) Apaf-1 and caspase 3 in p53-dependent apoptosis and tumor inhibition. Science, 284, 156-159. doi:10.1126/science.284.5411.156
[39] Puri, R.K. (2001) Cytotoxins directed at interleukin-4 receptors as therapy for brain tumors. Methods in Molecular Biology, 166, 155-176.